Libera Bio has been named today by the US National Foundation for Cancer Research (NFCR) as one of the three winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research. The Salisbury Award Competition is designed to catalyze and advance promising cancer research innovations onto a path of commercialization and patient impact.

More information: 2021 Salisbury Award Competition Winner Press Release